Endometrioid Borderline Ovarian Tumor: Clinical Characteristics, Prognosis, and Managements.
Ricotta G, Maulard A, Candiani M, Scherrier S, Genestie C, Pautier P, Leary A, Chargari C, Mangili G, Morice P, Gouy S.
Ann Surg Oncol. 2022 Sep;29(9):5894-5903. doi: 10.1245/s10434-022-11893-7. Epub 2022 May 19.
Intracystic endometrioid borderline tumor.
El Hajj H, Narducci F, McCluggage G, Pasquesoone C.
Int J Gynecol Cancer. 2023 Oct 2;33(10):1663-1665. doi: 10.1136/ijgc-2022-004151.
Ovarian cancer: epidemiology and risk factors.
La Vecchia C.
Eur J Cancer Prev. 2017 Jan;26(1):55-62. doi: 10.1097/CEJ.0000000000000217.
Endometriosis-associated cancer.
Guidozzi F.
Climacteric. 2021 Dec;24(6):587-592. doi: 10.1080/13697137.2021.1948994. Epub 2021 Jul 16.
Comparative study of endometrioid borderline ovarian tumor with and without endometriosis.
Zhang W, Jia S, Xiang Y, Yang J, Jia C, Leng J.
J Ovarian Res. 2018 Aug 11;11(1):67. doi: 10.1186/s13048-018-0440-x.
Mucinous Ovarian Tumors.
Mills AM, Shanes ED.
Surg Pathol Clin. 2019 Jun;12(2):565-585. doi: 10.1016/j.path.2019.01.008.
Brenner Borderline Ovarian Tumor: A Case Series and Literature Review.
Ricotta G, Maulard A, Genestie C, Pautier P, Leary A, Chargari C, Candiani M, Morice P, Gouy S.
Ann Surg Oncol. 2021 Oct;28(11):6714-6720. doi: 10.1245/s10434-021-09879-y. Epub 2021 Mar 25.
A rare mixed ovarian tumor associating borderline endometrioid component and borderline serous component.
Hammouda SB, Njima M.
Pan Afr Med J. 2022 Jan 26;41:73. doi: 10.11604/pamj.2022.41.73.30418. eCollection 2022.
Endometriosis-associated ovarian neoplasia.
Matias-Guiu X, Stewart CJR.
Pathology. 2018 Feb;50(2):190-204. doi: 10.1016/j.pathol.2017.10.006. Epub 2017 Dec 11.
Endometrioid borderline ovarian tumor arising from endometriotic cyst: short-term change of sonographic appearance.
Virgilio BA, Pontrelli G, Fattizzi N, Sacchi D, Basile F, Noventa M, Scioscia M.
Ultrasound Obstet Gynecol. 2020 May;55(5):692-694. doi: 10.1002/uog.21875.
